Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer
Study Details
Study Description
Brief Summary
RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet.
PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment for stage I, stage II, or stage III colorectal cancer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
OBJECTIVES:
Primary
- To characterize patterns and identify predictors of post-treatment physical activity and dietary changes made by colorectal cancer survivors.
Secondary
-
To identify the affective and cognitive effects of post-treatment physical activity and dietary changes in these patients.
-
To identify these patients' preferences regarding diet and physical activity health promotion programs.
OUTLINE: This is a multicenter study.
Patients complete surveys at baseline and at 3 and 6 months. A randomly selected subset of 84 patients also receive an activity monitor to be use at each of the 3 time points. The acceptability of their use is assessed and whether activity levels change across the 3 time points and the extent to which they are convergent with self-reported physical activity are examined.
During each survey, questionnaires are administered to assess the following areas:
physical/medical characteristics (self-reported), self-efficacy for physical activity, fruit and vegetable consumption, and dietary fat intake; outcome expectations for physical activity, fruit and vegetable consumption, and dietary fat intake; physical activity and diet behavioral self-regulation; illness representations (causal attributions and controllability of recurrence); perceived risk of colorectal cancer (CRC) recurrence; emotional representations of CRC (cancer-related anxiety and worry about cancer recurrence); healthcare provider recommendations to alter physical activity and dietary intake; social influence from important others; current physical activity and dietary intake; and diet and physical activity program preferences. Patients who received the activity monitor are asked feedback on acceptability of them.
Measures of sociodemographics and disease/treatment characteristics (via medical chart review) are recorded.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
cancer survivor cancer survivor |
Outcome Measures
Primary Outcome Measures
- Self-efficacy for changing physical activity and dietary practices [3 yrs]
- Outcome expectations with regard to physical activity and dietary practices [3 yrs]
- Behavioral self-regulation of physical activity and dietary practices [3 yrs]
- Perceived role of physical activity and dietary factors in causing colorectal cancer (CRC) and preventing recurrence (CRC illness representations) [3 yrs]
- Perceived risk of CRC recurrence [3 yrs]
- Cancer-related anxiety and worry about cancer recurrence (emotional representations of CRC) [3 yrs]
- Receipt of healthcare provider recommendations to alter physical activity and diet [3 yrs]
- Normative influences of family and friends [3 yrs]
Eligibility Criteria
Criteria
DISEASE CHARACTERISTICS:
-
Diagnosis of localized or regional colorectal cancer
-
Stage I, II, or III disease
-
Completed treatment within the past 6 weeks
-
No previous diagnosis of colorectal cancer
PATIENT CHARACTERISTICS:
-
English speaking
-
No current evidence of neoplastic disease except for nonmelanoma skin cancer
-
No evidence of severe cognitive impairment
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cooper Hospital/University Medical Center | Camden | New Jersey | United States | 08103 |
2 | JFK Medical Center in Edison | Edison | New Jersey | United States | 08818 |
3 | Centrastate Healthcare System | Freehold | New Jersey | United States | 07728 |
4 | Robert Wood Johnson University Hospital at Hamilton | Hamilton | New Jersey | United States | 08690 |
5 | Mountainside Hospital | Montclair | New Jersey | United States | 07042 |
6 | Morristown Medical Center | Morristown | New Jersey | United States | 07962 |
7 | Jersey Shore University Medical Center | Neptune | New Jersey | United States | 07754 |
8 | Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | United States | 08903 |
9 | Saint Peters University Hospital | New Brunswick | New Jersey | United States | 08903 |
10 | University Medical Center at Princeton | Princeton | New Jersey | United States | 08540 |
11 | Robert Wood Johnson University Hospital Somerset | Somerville | New Jersey | United States | |
12 | Overlook Medical Center | Summit | New Jersey | United States | 07901 |
13 | Fox Chase Cancer Center | Philadelphia | Pennsylvania | United States | |
14 | MD Anderson Cancer Center | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- Rutgers, The State University of New Jersey
- National Cancer Institute (NCI)
- Rutgers Cancer Institute of New Jersey
Investigators
- Principal Investigator: Elliot Coups, PhD, Rutgers Cancer Institute of New Jersey
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 130901
- R21CA131611
- P30CA072720
- K07CA133100
- CDR0000653167
- 0220090178